FDA inspection
Cipla Limited: FDA inspection ending Apr 17, 2026
FDA inspection 1313374 · Salcette
Key facts
| Inspection ID | 1313374 |
|---|---|
| Firm | Cipla Limited |
| FEI number | 3004081307 |
| Address | L139 To L146, S-103 To S-105, S-107 To S-112, L147 To L-147/1/2/3, L-147a, L-138, L-150, S-116, Verna Industrial Area |
| City | Salcette |
| Fiscal year | 2026 |
| Inspection end date | Apr 17, 2026 |
| Product type | Drugs |
At a glance
- 1–9 Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data